Ledger.Open graph →
SEC Form D · filed March 13, 2023

LEAP THERAPEUTICS, INC

Offering
$77.2M
Sold
$77.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Joseph K. Loscalzo · Cambridge, MADirectorChristine Granfield · Cambridge, MAExecNissim K. Mashiach · Cambridge, MADirectorChristopher K. Mirabelli · Cambridge, MADirectorAugustine K. Lawlor · Cambridge, MAExecWilliam K. Li · Cambridge, MADirectorThomas K. Dietz · Cambridge, MADirectorChristian K. Richard · Cambridge, MADirectorPatricia K. Martin · Cambridge, MADirectorCynthia K. Sirard · Cambridge, MAExecJames K. Cavanaugh · Cambridge, MADirectorRichard K. Schilsky · Cambridge, MADirectorMark K. O'Mahony · Cambridge, MAExecDouglas E. Onsi · Cambridge, MAExec · DirectorJoseph K. Loscalzo · Cambridge, MADirectorChristian K. Richard · Cambridge, MADirectorChristine Granfield · Cambridge, MAExecPatricia K. Martin · Cambridge, MADirectorNissim K. Mashiach · Cambridge, MADirectorChristopher K. Mirabelli · Cambridge, MADirectorCynthia K. Sirard · Cambridge, MAExecJames K. Cavanaugh · Cambridge, MADirectorRichard K. Schilsky · Cambridge, MADirectorAugustine K. Lawlor · Cambridge, MAExecWilliam K. Li · Cambridge, MADirectorThomas K. Dietz · Cambridge, MADirectorMark K. O'Mahony · Cambridge, MAExecDouglas E. Onsi · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗